Coya Therapeutics COYA
NASDAQ COYA
$4.14 +0.00 (+0.00%)
At close: Oct 22, 2026 · 4:00 PM EDT

Coya Therapeutics (COYA) Liabilities and Shareholders Equity (2021 - 2026)

Updated

Coya Therapeutics (COYA) reported Liabilities and Shareholders Equity of $47.31 million for Q2 2026, up 41.4% from $33.45 million a year earlier but down 11.2% from the prior quarter.

Analysis

Coya Therapeutics (COYA) Liabilities and Shareholders Equity (2021 - 2026) Analysis & Trends

At the end of FY2025, Coya Therapeutics posted Liabilities and Shareholders Equity of $49.95 million, up 12.6% from FY2024.

  • Liabilities and Shareholders Equity has increased for four consecutive years, with a four-year compound annual growth rate of 79.7% (FY2021 to FY2025).
  • By year, Liabilities and Shareholders Equity came in at $44.35 million in FY2024 (+7.5%), $41.26 million in FY2023 (+391.5%), $8.4 million in FY2022 (+75.2%) and $4.79 million in FY2021.
  • Five-year quarterly Liabilities and Shareholders Equity spans a low of $4.79 million in Q4 2021 and a high of $53.27 million in Q1 2026.
  • Year over year, Liabilities and Shareholders Equity has now increased in each of the last three quarters, with growth averaging 34.5% over the last eight quarters.
  • The high point for year-over-year Liabilities and Shareholders Equity in five years was Q4 2023 (growth of 391.5%); the low point was Q2 2025 (a decline of 16.2%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $53.27 million (Q1 2026), $49.95 million (Q4 2025) and $32.04 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn 142.28 Bn
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn 197.43 Bn
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn 135.12 Bn
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn 129.80 Bn
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn 122.03 Bn
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn 115.83 Bn
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn 95.64 Bn
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn 49.36 Bn
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn 201.13 Bn
10 Coya Therapeutics 97.12 Mn -71.76 Mn - 47.31 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 47.31 Mn
Mar 31, 2026 53.27 Mn
Dec 31, 2025 49.95 Mn
Sep 30, 2025 32.04 Mn
Jun 30, 2025 33.45 Mn
Mar 31, 2025 38.40 Mn
Dec 31, 2024 44.35 Mn
Sep 30, 2024 35.55 Mn
Jun 30, 2024 39.94 Mn
Mar 31, 2024 37.39 Mn
Dec 31, 2023 41.26 Mn
Sep 30, 2023 11.90 Mn
Jun 30, 2023 14.47 Mn
Mar 31, 2023 17.42 Mn
Dec 31, 2022 8.40 Mn
Dec 31, 2021 4.79 Mn
API Access

Coya Therapeutics Liabilities and Shareholders Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=COYA&period=max&api_key=YOUR_API_KEY